Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc covers the month of August 2026, specifically reporting on share buyback activities announced on August 17, 2026. Haleon is a consumer health company focused on categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on capital structure changes via share repurchases.
- Total Shares Purchased: 10,995,213 ordinary shares for cancellation.
- Share Price Range: Purchases occurred between 355.80p and 367.00p per share.
- Registered Share Capital: 8,809,911,209 ordinary shares of £0.01 each.
- Treasury Shares: 11,807,443 shares held as treasury.
- Voting Shares: 8,798,103,766 ordinary shares with voting rights.
Material Changes
The primary material change is the reduction of the company's share count through the cancellation of approximately 11 million shares under the buyback programme announced on March 12, 2026. Purchases were executed across multiple venues (London Stock Exchange, CBOE UK/BXE, CBOE UK/CXE, Aquis) between August 11 and August 13, 2026. No purchases were made on August 10 or August 14.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It includes a standard disclaimer that the announcement does not constitute an offer or solicitation for securities. A full breakdown of individual trades is referenced as available via the London Stock Exchange and the company's investor website.
Investor Verification Checklist
- Verify the total number of shares cancelled (10,995,213) against the updated share count on the company's investor relations page.
- Confirm the current number of voting shares (8,798,103,766) for disclosure threshold calculations under FCA rules.
- Review the detailed trade breakdown at the provided RNS link for specific execution prices and volumes per venue.
- Check subsequent filings for updates on the remaining capacity of the share buyback programme announced in March 2026.